Power harvesting for implanted medical devices: Junction Brief – November 2026

Acentric Research is produced with AI tools under human review. The authors are not financial professionals, and nothing here is investment advice or a recommendation to buy or sell any security. AI analysis can be wrong; check every claim against its cited source.

This Brief is an initial scan, not a full investigation. The method and scores behind it are in Biotechnology × Energy in the Landscape Report.

Overview

Pacemakers and similar implanted devices have run on batteries. A 2025 review says conventional batteries in implanted devices limit longevity and size and call for periodic replacement or recharging. [1] This Brief covers devices that instead make power inside the body: harvesters that turn the heart's motion into electricity, with wireless power sent from outside the body also in scope. The work described here sits at the stage of laboratory prototypes tested in animals.

The sources opened date from 2019 to 2026: a 2019 news article about work at Dartmouth College, a 2024 open-access paper on a pacemaker tested in swine, and two reviews from 2025 and 2026 that were read as abstracts only. No company was found, and no source describes a human trial. Later developments and commercial work were not searched.

Current state

What the technology does. Piezoelectric materials produce a voltage when they are bent; triboelectric devices produce charge when two materials touch and separate. Both can turn the heart's motion into electricity. The Dartmouth engineers described a harvester of piezoelectric thin films, built as a dual cantilever, that attaches to a pacemaker lead: the heart's motion moves the lead, which deforms the films. [2] The 2025 review lists other approaches: heartbeat and tissue motion, ultrasound wireless power transfer, electromagnetic harvesting, thermoelectric generators that use body temperature gradients, and biofuel cells that use glucose. [1]

Who is working on it. The sources describe academic groups. The Dartmouth team said it had conducted a first round of animal studies and was working on improving the device's efficacy, scalability and multi-functionality. [2] The swine study's authors, whose research was funded in part by Chinese national and Beijing science programmes and by a Fuwai Hospital research fund, describe a capsule weighing 1.75 grams with a volume of 1.52 cubic centimetres. [3] The Landscape Report found no verified funded programme and no capital event. [4] The Dartmouth paper, according to the news article, was a cover story in the journal Advanced Materials Technologies; the article does not give its date of publication in the journal. [2]

How far it has come. Tested in animals. The Dartmouth team said it had run a first round of animal studies, and the article says further animal experiments would be needed before tests in people. [2] The swine capsule was delivered through a vein by catheter into the right ventricle, converted heart motion into electricity and kept the heart paced during a three-week follow-up. [3] The authors describe their device as based on the coupled effect of triboelectrification and electrostatic induction, and as treating arrhythmia in large animal models. [3] The Landscape Report found no implant powered by a harvester in FDA's device databases and did not search ClinicalTrials.gov. [4] No source opened reports a first-in-human study. For power sent from outside the body, a 2026 review says implants with wireless power are employed in applications such as deep brain stimulators, capsule endoscopes, pacemakers and cardiac monitors, "which are being commercialized"; no product or approval was checked. [5]

Opportunities

The Dartmouth researchers say the design could be miniaturized and integrated within existing pacemakers, and could later power "any other implantable biomedical devices that need a sustainable power source". [2] The article, in its own words rather than the researchers', says pacemakers and defibrillators now need to be replaced every few years to swap out depleted batteries. [2] The swine study's authors say a constant energy supply would avoid the risk of a replacement operation when an implant's energy runs out, and that the polymer construction suggests the device could be compatible with MRI scans. [3] The 2025 review says harvesting offers dual functionality, enhanced penetration capabilities and access to inexhaustible energy reservoirs from bodily movements. [1]

Challenges

  • Power. In the swine capsule in the animal, the open-circuit voltage was about 6.0 volts and the short-circuit current about 0.2 microamps. The authors report a maximum power density of 2,200 milliwatts per cubic metre at a load of 100 megohms, and a stable voltage after 6 million stimulation cycles on a test machine. [3]
  • Evidence in humans. One Dartmouth researcher said commercialization was likely to take a while; the article adds that more animal experiments would be needed before human tests. [2] The swine follow-up was three weeks. [3]
  • Trade-offs. The 2025 review describes its aim as overcoming trade-offs between biocompatibility, power density and clinical viability. [1]
  • Wireless link design. For power sent from outside, efficiency, data rate, power use and circuit complexity must be balanced. [5]

Data sources

The sources below are where a deeper investigation would look; those marked "listed" were not searched for this Brief.

  • FDA device databases, for implants with a harvester or wireless power source. [6]
  • ClinicalTrials.gov, for human studies. [7]
  • Europe PMC, for papers on harvesters and wireless implant power. [8]
  • No registry of research groups or companies was found.

Changelog

  • 2026-11-19: First published.

Sources

  1. Liang, Y. et al., "Sustainable power solutions for next-generation medical devices", Materials Today Bio, 2025-07-04 (review; abstract read via Europe PMC). doi.org (accessed 2026-11-19)
  2. Digital Trends, "Energy-harvesting gizmo powers medical implants using your own heartbeat", 2019-02-07 (trade press quoting the Dartmouth researchers). digitaltrends.com (accessed 2026-11-19)
  3. Liu, Z. et al., "A self-powered intracardiac pacemaker in swine model", Nature Communications, 2024-01-13 (open-access paper; full text read via Europe PMC). doi.org (accessed 2026-11-19)
  4. Acentric Research, Landscape Report, November 2026, Biotechnology × Energy section and Exclusions. acentricresearch.com (accessed 2026-11-19)
  5. Ullah, N. et al., "Wireless Power and Data Transfer over Inductive Links for Biomedical Applications: Recent Advances, Challenges, and Limitations", Micromachines, 2026-08-24 (review; abstract read via Europe PMC). doi.org (accessed 2026-11-19)
  6. US Food and Drug Administration, device databases (premarket approval, 510(k), De Novo). accessdata.fda.gov(listed as a data source; not searched for this Brief)
  7. ClinicalTrials.gov, US National Library of Medicine. clinicaltrials.gov (listed as a data source; not searched for this Brief)
  8. Europe PMC, literature search. europepmc.org (listed as a data source; the records cited here were opened)